CSPC Pharmaceutical Group's (HKG:1093) Dividend Is Being Reduced To CN¥0.10
May 22
Have your own idea? Try our Stock Screener
Hong Kong (HSI) Pharma Industry Analysis
UpdatedMay 22, 2025
DataAggregated Company Financials
Companies39
- 7D8.8%
- 3M24.1%
- 1Y20.4%
- YTD31.0%
The Pharma industry is up 8.8% in the last week, with Hansoh Pharmaceutical Group up 14%. This takes the industry's 12 month performance to a gain of 20%. As for the next few years, earnings are expected to grow by 11% per annum.
Industry Valuation and Performance
Has the Hong Kong Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 22 May 2025 | HK$547.6b | HK$476.3b | HK$29.1b | 10.9x | 18.8x | 1.1x |
| Sat, 19 Apr 2025 | HK$473.0b | HK$466.5b | HK$28.6b | 10.2x | 16.5x | 1x |
| Mon, 17 Mar 2025 | HK$464.1b | HK$465.2b | HK$32.0b | 9.1x | 14.5x | 1x |
| Wed, 12 Feb 2025 | HK$420.7b | HK$461.1b | HK$31.8b | 8.6x | 13.2x | 0.9x |
| Fri, 10 Jan 2025 | HK$409.5b | HK$458.9b | HK$31.7b | 8.3x | 12.9x | 0.9x |
| Sun, 08 Dec 2024 | HK$443.5b | HK$462.5b | HK$31.9b | 8.3x | 13.9x | 1x |
| Tue, 05 Nov 2024 | HK$447.2b | HK$473.0b | HK$32.8b | 8.2x | 13.6x | 0.9x |
| Thu, 03 Oct 2024 | HK$498.2b | HK$477.7b | HK$33.1b | 7.9x | 15x | 1x |
| Sat, 31 Aug 2024 | HK$444.1b | HK$475.6b | HK$33.3b | 7.8x | 13.3x | 0.9x |
| Mon, 29 Jul 2024 | HK$422.3b | HK$458.9b | HK$32.6b | 7.5x | 13x | 0.9x |
| Wed, 26 Jun 2024 | HK$446.0b | HK$462.1b | HK$33.8b | 7.8x | 13.2x | 1x |
| Fri, 24 May 2024 | HK$466.7b | HK$462.9b | HK$33.7b | 8.5x | 13.8x | 1x |
| Sun, 21 Apr 2024 | HK$423.1b | HK$464.6b | HK$33.8b | 7.5x | 12.5x | 0.9x |
| Tue, 19 Mar 2024 | HK$468.8b | HK$470.2b | HK$33.3b | 7.8x | 14.1x | 1x |
| Thu, 15 Feb 2024 | HK$413.8b | HK$471.1b | HK$33.6b | 6.6x | 12.3x | 0.9x |
| Sat, 13 Jan 2024 | HK$456.0b | HK$472.1b | HK$33.7b | 7.6x | 13.5x | 1x |
| Mon, 11 Dec 2023 | HK$471.9b | HK$471.9b | HK$33.7b | 7.4x | 14x | 1x |
| Wed, 08 Nov 2023 | HK$495.7b | HK$469.5b | HK$31.9b | 7x | 15.5x | 1.1x |
| Fri, 06 Oct 2023 | HK$436.3b | HK$469.5b | HK$31.6b | 6.6x | 13.8x | 0.9x |
| Sun, 03 Sep 2023 | HK$428.9b | HK$470.9b | HK$31.5b | 6.9x | 13.6x | 0.9x |
| Tue, 01 Aug 2023 | HK$489.4b | HK$446.9b | HK$27.9b | 9.2x | 17.5x | 1.1x |
| Thu, 29 Jun 2023 | HK$500.1b | HK$445.5b | HK$27.5b | 9.6x | 18.2x | 1.1x |
| Sat, 27 May 2023 | HK$519.2b | HK$449.4b | HK$28.0b | 8.6x | 18.5x | 1.2x |
| Mon, 24 Apr 2023 | HK$566.8b | HK$454.3b | HK$28.8b | 9.1x | 19.6x | 1.2x |
| Wed, 22 Mar 2023 | HK$550.9b | HK$443.0b | HK$35.1b | 10.5x | 15.7x | 1.2x |
| Fri, 17 Feb 2023 | HK$602.5b | HK$445.8b | HK$35.4b | 10.9x | 17x | 1.4x |
| Sun, 15 Jan 2023 | HK$649.2b | HK$448.8b | HK$35.8b | 11.5x | 18.1x | 1.4x |
| Tue, 13 Dec 2022 | HK$618.8b | HK$441.3b | HK$34.6b | 10.8x | 17.9x | 1.4x |
| Thu, 10 Nov 2022 | HK$571.7b | HK$435.3b | HK$33.7b | 8.8x | 17x | 1.3x |
| Sat, 08 Oct 2022 | HK$527.2b | HK$516.1b | HK$39.3b | 7.9x | 13.4x | 1x |
| Mon, 05 Sep 2022 | HK$554.9b | HK$521.7b | HK$41.3b | 9x | 13.4x | 1.1x |
| Wed, 03 Aug 2022 | HK$568.0b | HK$512.2b | HK$51.8b | 7.5x | 11x | 1.1x |
| Fri, 01 Jul 2022 | HK$639.3b | HK$514.5b | HK$51.9b | 10x | 12.3x | 1.2x |
| Sun, 29 May 2022 | HK$580.9b | HK$514.5b | HK$51.9b | 8.7x | 11.2x | 1.1x |
Price to Earnings Ratio
11.2x
Current Industry PE
- Investors are optimistic on the Hong Kong Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 18.8x which is higher than its 3-year average PE of 14.8x.
- The industry is trading close to its 3-year average PS ratio of 1.1x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 18% per year over the last three years,
- Revenues have also declined 2.5% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the Hong Kong Healthcare industry?
| HK Market | 1.56% | |
| Healthcare | 7.71% | |
| Pharma | 8.84% | |
| Pharma | 8.84% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 3692 Hansoh Pharmaceutical Group | HK$25.70 | 13.7% +HK$18.4b | 48.7% | PE32.2x | |
| 1093 CSPC Pharmaceutical Group | HK$6.48 | 13.5% +HK$8.8b | 0.6% | PE15.8x | |
| 1177 Sino Biopharmaceutical | HK$4.21 | 7.9% +HK$5.5b | 43.7% | PE36.1x | |
| 2096 Simcere Pharmaceutical Group | HK$10.34 | 23.1% +HK$4.8b | 76.8% | PE32.1x | |
| 460 Sihuan Pharmaceutical Holdings Group | HK$0.91 | 37.9% +HK$2.3b | 56.9% | PS4x |
